Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) EBT Margin (2016 - 2025)

Pediatrix Medical (MD) has disclosed EBT Margin for 17 consecutive years, with 9.23% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin rose 260.0% to 9.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 11.31%, a 1634.0% increase, with the full-year FY2025 number at 11.31%, up 1634.0% from a year prior.
  • EBT Margin was 9.23% for Q4 2025 at Pediatrix Medical, down from 17.81% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 17.81% in Q3 2025 to a low of 33.26% in Q2 2024.
  • A 5-year average of 2.94% and a median of 6.38% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: tumbled -4104bps in 2024, then skyrocketed 4498bps in 2025.
  • Pediatrix Medical's EBT Margin stood at 10.73% in 2021, then plummeted by -50bps to 5.41% in 2022, then crashed by -617bps to 27.97% in 2023, then surged by 124bps to 6.63% in 2024, then skyrocketed by 39bps to 9.23% in 2025.
  • Per Business Quant, the three most recent readings for MD's EBT Margin are 9.23% (Q4 2025), 17.81% (Q3 2025), and 11.72% (Q2 2025).